Back to results
US 2026/0256177 A1Published application
Compositions derived from gastrointestinal tract mucins
AssigneeGnubiotics Sciences SA
InventorsAdeyemi Adesokan, Sara Lopez, Yong Miao
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and compositions comprising glycopeptides obtained from gastrointestinal sources that have superior microbiota effects. Such compositions are advantageous for food stuff, including infant formulations.
Claims11
A composition comprising glycopeptides obtained from gastrointestinal tract mucins, wherein:
- a) the composition is obtained without subjecting the mucins or a partially purified fraction thereof to conditions or reagents that release oligosaccharides from glycoproteins or glycopeptides;
- b) the total oligosaccharide content of the composition is >15% (w/w);
- c) the free glycan content of the composition is <1% (w/w);
- d) the total glycoprotein content of the composition is 6% or less (w/w);
- and
- e) the composition comprises glycopeptide-bound oligosaccharides having each of the following general formulae:
- i. Hex1HexNAc1Fuc1;
- ii. Hex1HexNAc2;
- iii. Hex1HexNAc2Fuc1;
- iv. Hex1HexNAc2Fuc1Sul1;
- v. Hex1HexNAc3;
- vi. Hex2HexNAc2;
- vii. Hex2HexNAc2Fuc1;
- viii. Hex2HexNAc2Fuc2;
- ix. Hex2HexNAc2Fuc2Sul1;
- x. Hex2HexNAc3;
- xi. Hex2HexNAc3Fuc1;
- xii. Hex2HexNAc4;
- xiii. Hex2HexNAc4Fuc1;
- and
- xiv. NeuAc1Hex1HexNAc2.
18 more elements
-87. (canceled)
Dependencies are inferred from the claim text.